Immunic is trading 5.7% lower at $8.15, with the reason for the October 2, 2026 decline unclear. - No clear company-specific announcement explaining the decline appeared in available search results. - Immunic’s investor-relations release list shows its latest release was September 29, concerning inducement grants. - The broader market is higher, supported by softer-than-expected September jobs data and falling rate-hike expectations; market-wide weakness does not explain Immunic’s drop.